Browse By Viral Diseases

This page shows data for Marburg hemorrhagic fever disease.
Total Entries Retrieved: 3
IDVaccine NameDisease NameDisease ClassificationVirus NameNucleic Acid ContentVaccine TypeVaccine StatusManufacturerYear of ManufacturingManufacturing CountryAgeDosageAdministration RouteAdjuvantTarget StrainDescriptionApproving OrganisationCollaborating OrganisationOther CountriesTrade NamePMIDClinical Trial IDReference LinkAdditional Links
10206 GEO-EM05 Marburg hemorrhagic fever Hemorrhagic Marburg virus negative-sense, single-stranded RNA Virus like particle Phase 1 GeoVax Labs Inc. NA USA NA NA Intramuscular NA NA NA NA NA NA NA NA NA https://www.biospace.com/article/geovax-announces-100-percent-protection-data-from-marburg-virus-vaccine-study/ NA
10207 AVI-6003 Marburg hemorrhagic fever Hemorrhagic Marburg virus negative-sense, single-stranded RNA NA Phase 1 Sarepta Therapeutics Inc. 2012 USA 18 - 55 years NA Intravenous NA NA NA NA NA NA NA NA NCT01353040 https://clinicaltrials.gov/ct2/show/NCT01353040?cond=Marburg+hemorrhagic+fever&draw=2&rank=1 NA
10208 cAd3 Marburg (VRC-MARADC087-00-VP) Marburg hemorrhagic fever Hemorrhagic Marburg virus negative-sense, single-stranded RNA Recombinant viral vector Phase 1 National Institute of Allergy and Infectious Diseases 2021 USA 18 - 50 years Single dose Intramuscular NA Marburg wild type glycoprotein NA US FDA US Military HIV Research Program NA NA NA NCT03475056 https://clinicaltrials.gov/ct2/show/NCT03475056?cond=Marburg+hemorrhagic+fever&draw=2&rank=3 NA